2vd7
From Proteopedia
(Difference between revisions)
(7 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
- | {{STRUCTURE_2vd7| PDB=2vd7 | SCENE= }} | ||
- | ===Crystal Structure of JMJD2A complexed with inhibitor Pyridine-2,4- dicarboxylic acid=== | ||
- | {{ABSTRACT_PUBMED_18942826}} | ||
- | == | + | ==Crystal Structure of JMJD2A complexed with inhibitor Pyridine-2,4- dicarboxylic acid== |
- | [[2vd7]] is a 2 chain structure with sequence from [ | + | <StructureSection load='2vd7' size='340' side='right'caption='[[2vd7]], [[Resolution|resolution]] 2.25Å' scene=''> |
+ | == Structural highlights == | ||
+ | <table><tr><td colspan='2'>[[2vd7]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2VD7 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2VD7 FirstGlance]. <br> | ||
+ | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.25Å</td></tr> | ||
+ | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=NI:NICKEL+(II)+ION'>NI</scene>, <scene name='pdbligand=PD2:PYRIDINE-2,4-DICARBOXYLIC+ACID'>PD2</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> | ||
+ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2vd7 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2vd7 OCA], [https://pdbe.org/2vd7 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2vd7 RCSB], [https://www.ebi.ac.uk/pdbsum/2vd7 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2vd7 ProSAT]</span></td></tr> | ||
+ | </table> | ||
+ | == Function == | ||
+ | [https://www.uniprot.org/uniprot/KDM4A_HUMAN KDM4A_HUMAN] Histone demethylase that specifically demethylates 'Lys-9' and 'Lys-36' residues of histone H3, thereby playing a central role in histone code. Does not demethylate histone H3 'Lys-4', H3 'Lys-27' nor H4 'Lys-20'. Demethylates trimethylated H3 'Lys-9' and H3 'Lys-36' residue, while it has no activity on mono- and dimethylated residues. Demethylation of Lys residue generates formaldehyde and succinate. Participates in transcriptional repression of ASCL2 and E2F-responsive promoters via the recruitment of histone deacetylases and NCOR1, respectively.<ref>PMID:16024779</ref> <ref>PMID:16603238</ref> <ref>PMID:21694756</ref> Isoform 2: Crucial for muscle differentiation, promotes transcriptional activation of the Myog gene by directing the removal of repressive chromatin marks at its promoter. Lacks the N-terminal demethylase domain.<ref>PMID:16024779</ref> <ref>PMID:16603238</ref> <ref>PMID:21694756</ref> | ||
+ | == Evolutionary Conservation == | ||
+ | [[Image:Consurf_key_small.gif|200px|right]] | ||
+ | Check<jmol> | ||
+ | <jmolCheckbox> | ||
+ | <scriptWhenChecked>; select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/vd/2vd7_consurf.spt"</scriptWhenChecked> | ||
+ | <scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview01.spt</scriptWhenUnchecked> | ||
+ | <text>to colour the structure by Evolutionary Conservation</text> | ||
+ | </jmolCheckbox> | ||
+ | </jmol>, as determined by [http://consurfdb.tau.ac.il/ ConSurfDB]. You may read the [[Conservation%2C_Evolutionary|explanation]] of the method and the full data available from [http://bental.tau.ac.il/new_ConSurfDB/main_output.php?pdb_ID=2vd7 ConSurf]. | ||
+ | <div style="clear:both"></div> | ||
+ | <div style="background-color:#fffaf0;"> | ||
+ | == Publication Abstract from PubMed == | ||
+ | The dynamic methylation of histone lysyl residues plays an important role in biology by regulating transcription, maintaining genomic integrity, and by contributing to epigenetic effects. Here we describe a variety of inhibitor scaffolds that inhibit the human 2-oxoglutarate-dependent JMJD2 subfamily of histone demethylases. Combined with structural data, these chemical starting points will be useful to generate small-molecule probes to analyze the physiological roles of these enzymes in epigenetic signaling. | ||
- | + | Inhibitor scaffolds for 2-oxoglutarate-dependent histone lysine demethylases.,Rose NR, Ng SS, Mecinovic J, Lienard BM, Bello SH, Sun Z, McDonough MA, Oppermann U, Schofield CJ J Med Chem. 2008 Nov 27;51(22):7053-6. doi: 10.1021/jm800936s. PMID:18942826<ref>PMID:18942826</ref> | |
- | <ref | + | |
- | [[Category: | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> |
- | [[Category: | + | </div> |
- | [[Category: | + | <div class="pdbe-citations 2vd7" style="background-color:#fffaf0;"></div> |
- | [[Category: Edwards | + | |
- | [[Category: Kavanagh | + | ==See Also== |
- | [[Category: McDonough | + | *[[Jumonji domain-containing protein 3D structures|Jumonji domain-containing protein 3D structures]] |
- | [[Category: Ng | + | == References == |
- | [[Category: Oppermann | + | <references/> |
- | [[Category: Pilka | + | __TOC__ |
- | [[Category: Savitsky | + | </StructureSection> |
- | [[Category: Schofield | + | [[Category: Homo sapiens]] |
- | [[Category: Sundstrom | + | [[Category: Large Structures]] |
- | [[Category: Weigelt | + | [[Category: Arrowsmith CH]] |
- | [[Category: | + | [[Category: Edwards A]] |
- | + | [[Category: Kavanagh KL]] | |
- | + | [[Category: McDonough MA]] | |
- | + | [[Category: Ng SS]] | |
- | + | [[Category: Oppermann U]] | |
- | + | [[Category: Pilka ES]] | |
- | + | [[Category: Savitsky P]] | |
- | + | [[Category: Schofield CJ]] | |
- | + | [[Category: Sundstrom M]] | |
- | + | [[Category: Weigelt J]] | |
- | + | [[Category: Von Delft F]] | |
- | + |
Current revision
Crystal Structure of JMJD2A complexed with inhibitor Pyridine-2,4- dicarboxylic acid
|
Categories: Homo sapiens | Large Structures | Arrowsmith CH | Edwards A | Kavanagh KL | McDonough MA | Ng SS | Oppermann U | Pilka ES | Savitsky P | Schofield CJ | Sundstrom M | Weigelt J | Von Delft F